ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag national security microbiology immunology neuroscience

Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Scientist Couples Do the Two-Job Shuffle
Myrna Watanabe | Apr 1, 2002 | 5 min read
Maria Sippola-Thiele journeyed from her native Finland with the goal of obtaining her doctoral degree in biochemistry at the University of Medicine and Dentistry of New Jersey (UMDNJ) and then returning home. But she met Dennis Thiele, a graduate student in microbiology, and her life took a different course. "He changed my plans to go back to Finland," Sippola-Thiele says. Her husband started his postdoctorate training at the National Cancer Institute (NCI), and Sippola-Thiele soon followed him
Turmoil Besets Wistar In Wake Of Koprowski's Ouster
Jean Wallace | Mar 1, 1992 | 10+ min read
The Wistar Institute in Philadelphia marks its 100th anniversary this year, but the mood at the nation's oldest independent biomedical research facility is hardly jubilant. The institute has been in turmoil for the last year, after the abrupt ouster of longtime director Hilary Koprowski, the famed virologist and immunologist who transformed Wistar from a dilapidated museum into a world-renowned research center. The commotion recently was stirred up further, when the 75-year-old Koprowski file
The Heart of Europe's Biotech Sector
Martina Habeck | Aug 1, 2004 | 6 min read
More than 5,000 scientists with higher academic degrees work in public research in Europe's Upper Rhine valley, making this area one of the highest densities of life sciences-related research in the world. Now, the triangle region from Basel, Switzerland, in the south to Strasbourg, France, and Freiburg, Germany, in the north is striving to become the European heart of the biotechnology sector.The Dreiländereck or la Régio, as the region is called locally, has a lot going for it: excel
Profiles of Infection
Douglas Steinberg(dsteinberg@the-scientist.com) | Nov 20, 2005 | 6 min read
Potential perils from bioterrorism to bird flu are increasingly pushing proteomics researchers to identify molecules involved in the infection process.
AIDS Investigators Cautiously Applauding Recent Advances
Steven Benowitz | Sep 29, 1996 | 10+ min read
Discoveries announced at conference leave scientists feeling optimistic; yet their enthusiasm is tempered by several persistent concerns. AIDS researchers have many reasons to be encouraged. Studies show that treatments combining new and old drugs can control HIV levels in the blood. Moreover, many scientists and activists note, prevention efforts have helped reduce HIV infection rates. Yet the enthusiasm is tempered by several caveats. Drugs are expensive and have harsh side effects, leading

Run a Search

ADVERTISEMENT